Agoracom Blog Home

Author Archive

Esports Entertainment Group $GMBL Engages Akur Capital for #iGaming Mergers and Acquisitions Advisory $DKNG $PENN $GAN $ESPO $AESE $EGLX.ca $BRAG.ca $FDM.ca

Posted by AGORACOM-JC at 7:11 AM on Wednesday, July 8th, 2020
  • Engaged Akur Capital as the Company’s iGaming mergers and acquisitions advisor
  • Akur Capital is a leading cross-border M&A advisory firm, specializing in the iGaming and sports betting sector

BIRKIRKARA, Malta, July 08, 2020 – Esports Entertainment Group, Inc. (NasdaqCM: GMBL, GMBLW) (or the “Company”), a licensed online gambling company with a focus on esports wagering and 18+ gaming, engaged Akur Capital (“Akur”) as the Company’s iGaming mergers and acquisitions advisor. Akur Capital is a leading cross-border M&A advisory firm, specializing in the iGaming and sports betting sector.

“We just signed with Akur and are already evaluating multiple potential M&A opportunities they’ve introduced to us,” commented Grant Johnson, CEO of Esports Entertainment Group. “The Akur team has years of iGaming and gambling experience and an extensive network of industry contacts. As the first US-based iGaming company to list on NASDAQ, we’re in a great position to capitalize on these highly fragmented markets and believe Akur will prove to be a valuable partner in our ongoing success.”

Esports Entertainment Group CEO Grant Johnson has been invited to present at The emergence of eSports webinar, presented by Maxim Group and M-Vest on Thursday, July 9, 2020.

Johnson will participate in a webinar panel discussion on the emergence of eSports. In contrast to many other industries that have and continue to experience significant setbacks as a result of COVID-19 – the global pandemic has arguably served as a positive catalyst for the world of eSports – an industry that continues to evolve and further expand to new audiences. During the panel discussion, Johnson will discuss the eSports industry, its major players, and factors driving market growth.

To access the panel discussion, please RSVP

Webinar Details:

  • Panel Session Title: The Emergence of eSports

  • Date and Time: Thursday, July 9, 11:00 a.m. Eastern time (8:00 a.m. Pacific time)

ABOUT ESPORTS ENTERTAINMENT GROUP

Esports Entertainment Group, Inc. is a licensed online gambling company with a specific focus on esports wagering and 18+ gaming. Esports Entertainment offers fantasy, pools, fixed odds and exchange style wagering on esports events in a licensed, regulated and secure platform to the global esports audience at vie.gg.  In addition, Esports Entertainment intends to offer users from around the world the ability to participate in multi-player mobile and PC video game tournaments for cash prizes. Esports Entertainment is led by a team of industry professionals and technical experts from the online gambling and the video game industries, and esports. The Company holds a license to conduct online gambling and 18+ gaming on a global basis in Curacao, Kingdom of the Netherlands. The Company maintains offices in Malta. For more information visit www.esportsentertainmentgroup.com

FORWARD-LOOKING STATEMENTS

The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The safe harbor for forward-looking statements contained in the Securities Litigation Reform Act of 1995 protects companies from liability for their forward-looking statements if they comply with the requirements of the Act.

Contact:

U.S. Investor Relations 
RedChip Companies, Inc.
Dave Gentry
407-491-4498
[email protected]

Media & Investor Relations Inquiries
AGORACOM
[email protected]
http://agoracom.com/ir/eSportsEntertainmentGroup

Esports Entertainment Group $GMBL Signs Definitive Agreement to Acquire Online Sportsbook and Casino Operator Argyll Entertainment $DKNG $PENN $GAN $ESPO $AESE $EGLX.ca $BRAG.ca $FDM.ca

Posted by AGORACOM-JC at 9:20 AM on Tuesday, July 7th, 2020
  • Signed a definitive agreement to acquire LHE Enterprises Ltd, the holding company of online sportsbook and casino operator Argyll Entertainment AG and its operating subsidiaries
  • Closing of the acquisition is expected to occur on or before July 31, 2020
  • “As a fast growing and innovative online gaming company licensed in the UK and Ireland, Argyll offers Esports Entertainment Group access to exclusive and proprietary sports and gaming content, including the flagship SportNation.bet brand and an award-winning rewards program, which was a major driver of Argyll’s $12 million in revenue in 2019,”

BIRKIRKARA, Malta, July 07, 2020 – Esports Entertainment Group, Inc. (NasdaqCM: GMBL, GMBLW) (or the “Company”), a licensed online gambling company with a focus on esports wagering and 18+ gaming, signed a definitive agreement to acquire LHE Enterprises Ltd, the holding company of  online sportsbook and casino operator Argyll Entertainment AG and its operating subsidiaries (”Argyll”).  Closing of the acquisition is expected to occur on or before July 31, 2020. 

“Reaching a definitive agreement to complete our first acquisition as a NASDAQ company is a major milestone,” commented Grant Johnson, CEO of Esports Entertainment Group. “Argyll CEO Stuart Tilly and CFO Dan Marks already joined our senior leadership team in June as Corporate Secretary and Chief Financial Officer, respectively. They are a great addition to our organization and will help us build on Argyll’s base of more than 100,000 registered users, placing us in a great position to grow revenue moving forward.”

“As a fast growing and innovative online gaming company licensed in the UK and Ireland, Argyll offers Esports Entertainment Group access to exclusive and proprietary sports and gaming content, including the flagship SportNation.bet brand and an award-winning rewards program, which was a major driver of Argyll’s $12 million in revenue in 2019,” added Tilly. “The esports industry is the strongest it’s ever been, and the strengthened financial position of our combined operations together with the ability to leverage the expertise and deep domain knowledge of its 30 strong staff in marketing, technology, risk management, and regulation will put Esports Entertainment Group in a great position to capitalize on the wealth of opportunities ahead in this rapidly growing market.”

Argyll, incorporated in Switzerland, with operational support services in London, UK and Malta, is licensed and regulated by the UK Gambling Commission under licence no. 000-045143-R-323955-001 and the Irish Revenue Commissioners under licence reference no. 1014456 to operate online sportsbook and casino sites in the UK and Ireland, respectively.

ABOUT ESPORTS ENTERTAINMENT GROUP

Esports Entertainment Group, Inc. is a licensed online gambling company with a specific focus on esports wagering and 18+ gaming. Esports Entertainment offers fantasy, pools, fixed odds and exchange style wagering on esports events in a licensed, regulated and secure platform to the global esports audience at vie.gg.  In addition, Esports Entertainment intends to offer users from around the world the ability to participate in multi-player mobile and PC video game tournaments for cash prizes. Esports Entertainment is led by a team of industry professionals and technical experts from the online gambling and the video game industries, and esports. The Company holds a license to conduct online gambling and 18+ gaming on a global basis in Curacao, Kingdom of the Netherlands. The Company maintains offices in Malta. For more information visit www.esportsentertainmentgroup.com


FORWARD-LOOKING STATEMENTS

The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The safe harbor for forward-looking statements contained in the Securities Litigation Reform Act of 1995 protects companies from liability for their forward-looking statements if they comply with the requirements of the Act.

Contact:

U.S. Investor Relations 
RedChip Companies, Inc.
Dave Gentry
407-491-4498
[email protected]

Media & Investor Relations Inquiries
AGORACOM
[email protected]
http://agoracom.com/ir/eSportsEntertainmentGroup

Else Nutrition $BABY.ca Receives Key Clean Label Certifications Ahead of U.S. Launch of Toddler Nutrition Product $KMB $BMY $ABT $WYE

Posted by AGORACOM-JC at 7:08 AM on Tuesday, July 7th, 2020
http://blog.agoracom.com/wp-content/uploads/2020/03/else-square-150x150.png
  • Plant-based, Clean Label and Soy-Free Certifications Granted
  • Received multiple key certifications
  • Certifying organizations apply independent and rigorous testing to ensure their certification meets a standard which enables transparency with respect to food and consumer product labeling and to preserve public health and safety for U.S. consumers

VANCOUVER, BC, July 7, 2020 – ELSE NUTRITION HOLDINGS INC. (TSXV: BABY) (OTCQB: BABYF) (FSE: 0YL) (“Else” or the “Company”), is pleased to announce that its novel, plant-based complete nutrition product for toddlers has received multiple key certifications.

Following successful production, consultations and reviews, the toddler nutrition product is now certified by the following leading independent organizations:

  1. The Clean Label ProjectTM for being a certified clean label product.

  2. NSF International (owned by the Plant-Based Foods Association) for being a Certified Plant-based product.

  3. Beyond Soy for being certified as a soy-free product.

The certifying organizations apply independent and rigorous testing to ensure their certification meets a standard which enables transparency with respect to food and consumer product labeling and to preserve public health and safety for U.S. consumers.

Attaining these product certificates demonstrates Else’s commitment towards creating and providing safe, clean label, plant-based, dairy-free and soy-free nutrition products.

This month, customers in the U.S. will be able to pre-order the full-sized Else Nutrition Plant-Based Complete Nutrition for Toddlers on the Else e-store at: www.elsenutrition.com.

“We are excited to be continuing on our pathway to commercialization.  Obtaining these certifications is a major step as we prepare for our U.S. launch.  This independent validation of our clean label product is a critical element of our go to market strategy and positioning,” said Ms. Hamutal Yitzhak, CEO and Co-Founder of Else.

About Else Nutrition Holdings Inc.

Else Nutrition GH Ltd. is an Israel-based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the “2017 Best Health and Diet Solutions” award at the Global Food Innovation Summit in Milan. The holding company, Else Nutrition Holdings Inc, is a publicly-traded company, listed as TSX Venture Exchange under the trading symbol BABY and is quoted on the US OTC Markets QB board under the trading symbol BABYF and on the Frankfurt Exchange under the symbol 0YL. Else’s Executive and Advisory Board includes leaders hailing from Abbott Nutrition, Mead Johnson, Boston Children’s Hospital, ESPGHAN (European Society for Pediatric Gastroenterology, Hepatology and Nutrition). Plum Organics, Tel Aviv University’s Sackler Faculty of Medicine, and Gastroenterology & Nutrition Institute of RAMBAM Medical Center.

For more information, visit: elsenutrition.com or @elsenutrition on Facebook and Instagram.

TSX Venture Exchange

Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Caution Regarding Forward-Looking Statements

This press release contains statements that may constitute “forward-looking statements” within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as “will” or similar expressions. Forward-looking statements in this press release include statements with respect to the anticipated dates for filing the Company’s financial disclosure documents. Such forward-looking statements reflect current estimates, beliefs and assumptions, which are based on management’s perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Forward-looking statements made in this press release assume, among othersForward-looking statements made in this press release assume, among others, the timing of the Company’s toddler nutrition product launch and the availability of the Company’s product online. Actual results may differ from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements.  Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management’s expectations only as of the date of this press release. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

SOURCE Else Nutrition Holdings Inc.

Empower Clinics $CBDT.ca – 5 positive testimonials on medical marijuana benefits from real patients $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 4:30 PM on Monday, July 6th, 2020

SPONSOR:

Why Empower Clinics

  • A leading owner/operator of physician staffed health and pain management clinics.
  • Patient database of over 165,000 patients 
  • Proprietary technology platforms including Electronic Health Records portal and e-Commerce for CBD product distribution
  • Recently launched CBD extraction facility
  • First extraction system capacity = 2,300 Kg per year.
  • CBD based products are poised to be a $20B global industry by 2022
  • Medical cannabis is poised to be a $100B global industry by 2025
  • Company to Create Psilocybin and Psychadelics Division Leveraging Corporate Wellness Clinics and Franchise Clinic
  • Commenced tele-medicine services for patients, both in-clinics and virtually through secure video, on browser and in mobile app
  • Successfully conducted COVID-19 antibody business employee testing, solidifying the importance of phase three of the testing program
  • Conducted 2,302 physician-patient consultations setting a new milestone in patient volume for the month of May

—————————

5 positive testimonials on medical marijuana benefits from real patients

By: Pearce Thompson

We’d like to shine a light on a few patients in this article, to share their insights and experiences on how medical marijuana has benefited them throughout their illness. Please take the time to read through the list of 5 testimonials from real patients who have had positive outcomes from using the herb for their treatments.

If you want to view the history of medical marijuana referenced above, click here. If you want a timeline of the history of medical marijuana use in Canada, click here.

#1 Rebecca Swell an advocate of medical marijuana

When Rebecca was 10 years old she was diagnosed with Complex Regional Pain Syndrome, this condition comes from damage to the nervous system and causes extreme pain. Rebecca was forced into a walker or wheelchair from a young age, and when spinal cord stimulation and morphine didn’t work, she tried medical marijuana. Rebecca now needs no walking support, no morphine, and is an advocate of medical marijuana.

#2 Charlotte Figgi (Charlotte’s Web)

The story of Charlotte Figgi is more well known than most. Charlotte was diagnosed with a rare form of epilepsy at a young age and at 5 she experienced close to 300 mal seizures per week. The condition was so bad the doctor put her in a medically induced coma. In the first week of trying cannabis oil, Charlotte had no seizures. The strain created for her has no psychoactive effects and was renamed “Charlotte’s Web“.

#3 Ashley Surin

Ashly was diagnosed with Acute Lymphoblastic Leukemia, a type of cancer that affects white blood cells which makes it harder to fight infections. Ashley was also prone to seizures and her family moved to cannabis oil to aid this. The oil proved effective and is still used by Ashley to this day.

#4 Walter Rodlund

Walter Rodlund is from Fargo, ND and at the age 81 he enjoyed spending time outdoors his entire life. At this time he was diagnosed with Chronic Obstructive Pulmonary Disease, which decreased his lung capacity. With this condition, Walter could no longer enjoy the outdoors. His daughter recommended cannabis oil, Walter tried, Walter liked, Walter enjoys the outdoors again.

5. Beyla Pagano benefitted a lot by taking medical marijuana

From birth, Beyla had a large amount of cerebrospinal fluid built up in her brain. This caused seizures and doctors believed she would never walk or talk. The prescriptions given to her always put her in a drowsy state, so her family tried medical marijuana. The cannabis oil immediately improved her state, Beyla can walk, talk, and has seizures less frequently.

CLIENT FEATURE: Binovi Technologies $VISN.ca Creating Faster Brains Through Stronger Eyes $EYPT $KALA

Posted by AGORACOM-JC at 4:00 PM on Monday, July 6th, 2020
http://www.smallcapepicenter.com/binovi%20square.png

Trusted and used by some of the world’s top professional sports teams, including:

Why Binovi?

  • Binovi Has Already Started Commercializing Its Vision Therapy Platform
  • Company’s Vision Therapy Products Used In:
    • Over 1,500 Practices
    • 20 Countries
  • Flagship “Binovi” Is State-Of-The-Art Platform
    • Measures 14 Key Vision Skills
    • Essential For Maximizing Brain Performance
    • Shipped Over 400 Binovi Units (April 2020)
    • Goal Is 2,500 Binovi Units (End Of 2020)
  • Signed Sports Vision Partnership With Eli Wilson Goaltending
    • World Leader In Goaltending Development
    • 600 Active Goaltending Camp Participants
    • 50,000 Global Aspiring Goaltenders
  • Binovi is now well positioned to further commercialize and capitalize on massive demand for Vision Therapy and Training For Athletes and Education

THE MARKET OPPORTUNITY

  • Vision Therapy captures 3% of a $36B Yearly Vision Market today
  • Vision Therapy will grow by 22% this year and account for 4% of the $39B Yearly Market by year end
  • Sights are set on disrupting the sports performance industry in 2020 while receiving engagement from leaders within the human performance – sport performance industry
  • The size of the sports performance market reached a value of nearly $488.5B in 2018, having grown at a compound annual growth rate (CAGR) of 4.3% since 2014
  • Expected to grow at a CAGR of 5.9% to nearly $614.1B by 2022

Binovi Explained

Binovi Technologies is an advertising client of AGORA Internet Relations Corp.

Digital Health #Mhealth Funding Shatters Funding Records Despite #COVID Economy – SPONSOR: CardioComm Solutions $EKG.ca $ATE.ca $TLT.ca $OGI.ca $ACST.ca $IPA.ca

Posted by AGORACOM-JC at 3:40 PM on Monday, July 6th, 2020

SPONSOR: CardioComm Solutions (EKG: TSX-V) – The heartbeat of cardiovascular medicine and telemedicine. Patented systems enable medical professionals, patients, and other healthcare professionals, clinics, hospitals and call centres to access and manage patient information in a secure and reliable environment.

Digital Health Funding Shatters Funding Records Despite COVID Economy

  • Despite COVID-19, digital health funding shattered all previous venture capital funding records for the sector by raising $6.3 billion in the first half of the year (1H), according to Mercom Capital Group.
  • The Austin, TX-based firm reported that the digital health funding in 1H was 24% higher than the $5.1 billion the space raised in the first half of 2019, despite the pandemic disrupting the economy

By: Amanda Pedersen

Despite COVID-19, digital health funding shattered all previous venture capital funding records for the sector by raising $6.3 billion in the first half of the year (1H), according to Mercom Capital Group.

The Austin, TX-based firm reported that the digital health funding in 1H was 24% higher than the $5.1 billion the space raised in the first half of 2019, despite the pandemic disrupting the economy. Mercom Capital Group is previewewed this data in advance of its upcoming 1H Digital Health Funding and M&A Report, which is expected to be published July 13.

Interestingly enough, venture funding reached $2.8 billion during the second quarter of 2020, an 11% decrease year-over-year compared to $3.1 billion raised in Q2 2019. Healthcare practice-centric digital health companies received 34% of the funding in Q2 2020, raising $947 million in 56 deals, and consumer-centric digital health companies accounted for 66% of the funding, raising $1.8 billion in 105 deals.

“Adoption of digital health technologies and products have accelerated since the COVID-19 outbreak, which is reflected in the funding spike in the first half of the year. Telehealth hype has been backed by $2 billion in venture funding with no signs of slowing down,” said Raj Prabhu, CEO of Mercom Capital Group.

This confirms what MD+DI has previously reported regarding telemedicine trends that emerged during the early days of the pandemic.

Other categories that received significant funding during the second quarter include mHealth apps, analytics, wellness, and medical imaging, Mercom reported.

The top-funded digital health categories in 1H 2020 were: telehealth with $1.9 billion, followed by analytics with $826 million, mHealth apps with $794 million, clinical decision support with $545 million, healthcare service booking with $326, and wearable sensors with $321 million.

The top telehealth VC deals in 1H 2020 included: $194 million raised by Amwell (formerly American Well), $155 million raised by KRY, $144 million raised by Zhiyun Health, $100 million raised by Mindstrong, and $93 million raised by Virta Health. Telehealth funding was distributed in 85 companies during 1H 2020.

The top overall digital health VC deals in 1H 2020 included: $285 million raised by ClassPass, $250 million raised by Alto Pharmacy, $194 million raised by Amwell, $155 million raised by KRY, and $150 million raised by Concerto HealthAI. Digital Health funding was distributed in 27 different countries in 1H 2020.

Mercom Capital Group is a global communications and consulting firm that produces funding and market intelligence reports covering a variety of “cleantech” sectors.

Source: https://www.mddionline.com/digital-health/digital-health-funding-shatters-funding-records-despite-covid-economy

Labrador Gold $LAB.ca Expands Kingsway to 77 Square Kilometres With Option Agreement $RIO.ca $WHM.ca $SIC.ca $NXS.ca $NVO.ca

Posted by AGORACOM-JC at 11:54 AM on Monday, July 6th, 2020
http://blog.agoracom.com/wp-content/uploads/2020/03/LAB-square-logo.png
  • Entered into an option agreement to acquire 100% of License 023940M which is strategically positioned between the Kingsway North and South claim blocks in the emerging Gander gold belt
  • The acquisition of the Property increases the Company’s landholdings in the district to 308 claims or approximately 77 square kilometres

TORONTO, July 06, 2020 — Labrador Gold Corp. (TSX-V: LAB) (“LabGold” or the “Company”)  is pleased to announce that it has entered into an option agreement to acquire 100% of License 023940M ( the “Property”) which is strategically positioned between the Kingsway North and South claim blocks in the emerging Gander gold belt. The acquisition of the Property increases the Company’s landholdings in the district to 308 claims or approximately 77 square kilometres.

Property Highlights

  • Comprises 44 claim units contiguous with Kingsway North and South (see Figure 1)
  • Hosts the Cracker gold occurrence where grab samples from trenching range from 1.8 g/t Au to 61.73 g/t Au and channel samples range from <5ppb to 1.89 g/t Au (see Table 1)
  • Historical soil sampling show gold concentrations in samples of <5ppb to 787 ppb (0.787 g/t Au), including 19 samples over 100 ppb (0.1 g/t Au)
  • Historical till sampling in the northern portion of the Property close to the boundary with Kingsway North, show gold concentrations in samples of 0.11 g/t to 1.61 g/t and gold grain counts of 7 to 60 grains

Table 1. Highlights of historical rock sampling on the property.

Sample IDSample TypeLengthAu (g/t)
21027GrabN/A3.97
21028GrabN/A4.74
21029GrabN/A1.80
NK-1GrabN/A61.73
21034GrabN/A3.64
21038GrabN/A1.044
22127Channel0.5m1.89
22128Channel0.5m0.37

Note that grab samples are select samples and are not necessarily representative of gold mineralization found on the property. Channel sample lengths are not necessarily true widths. The Company has reviewed the assay certificates in the following assessment report and is satisfied that the results are accurately reported  Source: Saunders, J. and Pollet ,F. 2003  Second year assessment report on the prospecting activity on the South Pond Property License 7155M northeastern Newfoundland area NTS 2/E2.

“Optioning this strategic Property consolidates LabGold’s land position in the Gander gold belt and adds a significant  gold occurrence to the property package. The Cracker showing is another gold occurrence associated with the Appleton Fault Zone, a crustal-scale structure that we believe to be a major control of gold in the district,” said Roger Moss, President and CEO of LabGold. “We will include the Property in our exploration plans for this summer with work expected to begin around mid-July.”

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/3af1346b-724d-4eca-bd88-e46e01d9867e

Terms of Agreement

LabGold can earn an initial 75% undivided interest as follows:

  • Payment of $18,000.00 and issuing 30,000 common shares, within 5 business days of TSX Venture Exchange acceptance of the option agreement;
  • Payment of $36,000, issuing 90,000 shares and undertaking $100,000 work expenditure on or before the first anniversary of the option agreement;
  • Payment of $75,000 issuing 120,000 shares and undertaking $250,000 work expenditure on or before the second anniversary of the option agreement;
  • Payment of $90,000, issuing 150,000 shares and undertaking $650,000 work expenditure on or before the third anniversary of the option agreement;

If the Company has exercised the 75% option and satisfied all payment requirements, the Company has the Option to acquire the remaining 25% interest as follows:                      

Payment of $240,000 and undertaking work expenditure of $1,000,000 on or before the fourth anniversary of the date of this agreement, provided that the cash payment requirement may be fulfilled by the Company at its discretion by the issuance of common shares of equal value.

If the Company exercises the 75% Option but does not exercise the 25% Option by the 4th Anniversary, the parties will be associated in an unincorporated joint venture for the purpose of exploring and, if warranted, developing the Property (the “Joint Venture”). The terms and conditions of the Joint Venture shall be on industry standard terms and will be more fully laid out in an Option and Joint Venture Agreement.

The technical content of this news release was approved by Roger Moss Ph.D., P.Geo, President and CEO of the Company and a qualified person as defined by National Instrument 43-101.

About Labrador Gold:

Labrador Gold is a Canadian based mineral exploration company focused on the acquisition and exploration of prospective gold projects in the Americas.

In early March 2020, Labrador Gold acquired the option to earn a 100% interest in the Kingsway project in the Gander area of Newfoundland. The property is along strike to the northeast of New Found Gold’s discovery of 92.86 g/t Au over 19.0 metres on their Queensway property. (Note that mineralization hosted on adjacent or nearby properties is not necessarily indicative of mineralization hosted on the Company’s property). The two licenses comprising the Kingsway project cover approximately 16km of the Appleton fault zone which is associated with gold occurrences in the region, including the New Found Gold discovery. Historical work over the area covered by the Kingsway licenses shows evidence of gold in till, vegetation, soil, stream sediments, lake sediments and float. Infrastructure in the area is excellent located just 18km from the town of Gander with road access to the project, nearby electricity and abundant local water.

The Hopedale property covers much of the Florence Lake greenstone belt that stretches over 60 km. The belt is typical of greenstone belts around the world but has been underexplored by comparison. Initial work by Labrador Gold during 2017 show gold anomalies in soils and lake sediments over a 3 kilometre section of the northern portion of the Florence Lake greenstone belt in the vicinity of the known Thurber Dog gold showing where grab samples assayed up to 7.8g/t gold. In addition, anomalous gold in soil and lake sediment samples occur over approximately 40 kilometres along the southern section of the greenstone belt (see news release dated January 25th 2018 for more details).

The Ashuanipi gold project is located just 35 km from the historical iron ore mining community of Schefferville, which is linked by rail to the port of Sept Iles, Quebec in the south. The claim blocks cover large lake sediment gold anomalies that, with the exception of local prospecting, have not seen a systematic modern day exploration program. Results of the 2017 reconnaissance exploration program following up the lake sediment anomalies show gold anomalies in soils and lake sediments over a 15 kilometre long by 2 to 6 kilometre wide north-south trend and over a 14 kilometre long by 2 to 4 kilometre wide east-west trend. The anomalies appear to be broadly associated with magnetic highs and do not show any correlation with specific rock types on a regional scale (see news release dated January 18th 2018). This suggests a possible structural control on the localization of the gold anomalies. Historical work 30 km north on the Quebec side led to gold intersections of up to 2.23 grams per tonne (g/t) Au over 19.55 metres (not true width) (Source: IOS Services Geoscientifiques, 2012, Exploration and geological reconnaissance work in the Goodwood River Area, Sheffor Project, Summer Field Season 2011). Gold in both areas appears to be associated with similar rock types.

Following completion of this private placement, the Company has 85,610,451 common shares issued and outstanding and trades on the TSX Venture Exchange under the symbol LAB.

The technical content of this news release was approved by Roger Moss Ph.D., P.Geo, President and CEO of the Company and a qualified person as defined by National Instrument 43-101.

For more information please contact:             

Roger Moss, President and CEO      Tel: 416-704-8291

Or visit our website at: www.labradorgold.com

Twitter: @LabGoldCorp

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements: This news release contains forward-looking statements that involve risks and uncertainties, which may cause actual results to differ materially from the statements made. When used in this document, the words “may”, “would”, “could”, “will”, “intend”, “plan”, “anticipate”, “believe”, “estimate”, “expect” and similar expressions are intended to identify forward-looking statements. Such statements reflect our current views with respect to future events and are subject to risks and uncertainties. Many factors could cause our actual results to differ materially from the statements made, including those factors discussed in filings made by us with the Canadian securities regulatory authorities. Should one or more of these risks and uncertainties, such as actual results of current exploration programs, the general risks associated with the mining industry, the price of gold and other metals, currency and interest rate fluctuations, increased competition and general economic and market factors, occur or should assumptions underlying the forward looking statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, or expected. We do not intend and do not assume any obligation to update these forward-looking statements, except as required by law. Shareholders are cautioned not to put undue reliance on such forward-looking statements.

Datametrex $DM.ca Announces Another Sale of #COVID19 Test Kits for $850,000 to a Canadian Mining Company

Posted by AGORACOM-JC at 11:24 AM on Monday, July 6th, 2020
  • Announced a purchase order of 20,000 COVID-19 test kits from a Canadian based mining company with operations worldwide. This PO is for one of their Latin American mine operations
  • Total gross sales amount is approximately $850,000 CDN, excluding shipping and courier fees
  • The Company has secured all requested testing kits, swabs, tubes, and the PCR machines

TORONTO, July 06, 2020 – Datametrex AI Limited (the “Company” or “Datametrex“) (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce a purchase order (the “PO”) of 20,000 COVID-19 test kits from a Canadian based mining company (the “Purchaser”) with operations worldwide. This PO is for one of their Latin American mine operations.

The total gross sales amount is approximately $850,000 CDN, excluding shipping and courier fees. The Company has secured all requested testing kits, swabs, tubes, and the PCR machines. All of the items will be delivered directly to the mining company at their operating site in Latin America in mid-July. The Company anticipates little or no up front costs associated with the sale of these kits.

“Datametrex is assisting with the implementing of test kits as it is a fundamental response to the pandemic, and those mining companies that have been able to test more comprehensively have had greater success,” says Marshall Gunter, CEO of the Company. “The reasoning is simple: An individual who tests positive can be isolated until they recover, and their contacts may be traced and similarly tested and isolated, effectively reducing the rate of transmission.”

Under the terms of the PO, Datametrex will provide the Purchaser with 20,000 units of the COVID-19 qPCR Detection Kits manufactured by 1drop Inc. (“1drop”), 20,000 Universal Transport Medium (UTM®), Sterile Swabs with 16x100mm and Skirted Tubes. The Company also sold two (2) Real-Time Polymerase Chain Reaction Detection System (“PCR”) machines along with software to ensure optimal assay performance of the samples.

Some Latin American countries are seeing shocking unemployment figures as the pandemic has caused hunger to rise in the region. The fallout from the pandemic is being felt hardest in Latin America, and has seen an almost three-fold rise in the number of people requiring government assistance, and among urban communities in low and middle-income countries, which are being dragged into destitution by job losses, especially in the mining sector. Millions of people are out of work in Brazil, Chile and Colombia, which have all attempted to re-open sectors of their economies but were hit with fast-spreading infections.

About 1drop Inc.

1drop Inc. aims to provide a solution to manage health with a drop of fluid. It has the key technologies for becoming a global leading company in the field of smart health care. 1copy™ COVID-19 qPCR Multi Kit can reduce the risk of asymptomatic and latent infection of COVID-19 by a single virus level limit of detection. Additional information on 1drop Inc. is available at www.1drop.co.kr

About Datametrex

Datametrex AI Limited is a technology-focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational Health and Safety goals with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, the Company provides progressive solutions to support the supply chain.

Additional information on Datametrex is available at www.datametrex.com

For further information, please contact:

Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

You’re Invited to $KABN.ca North America Showcase this Week – Register Now! $MOS.ca $MOGO.ca $CTZ.ca $PTO.ca $PAY.ca

Posted by AGORACOM-JC at 9:49 AM on Monday, July 6th, 2020
This image has an empty alt attribute; its file name is image-3.png

We’re inviting you to join the KABN North America Showcase presented by company Leadership Team  

Join us as we provide the business, technology and investment community with an overview of the KABN North America platform   KABN believes that ownership of identity is a basic human right and individuals should be the primary beneficiary of any use of their identity.   KABN’s product suite offers:

KABN North America has 4 primary products that enable users to verify, manage and monetize their digital identity:

  • KABN ID: a reusable, Always On, compliant, biometrically based, identity   verification and validation platform that forms the engine of the KABN Network.
  • LIQUID AVATAR: a digital image-based “wallet and keyring” platform that allows users to manage their digital identity.
  • KABN Card: an approved prepaid Visa card that includes a mobile banking wallet that supports both digital and traditional currencies.
  • KABN KASH: a robust loyalty and engagement platform with cashback and card-linked programs. 

If you haven’t already, please register at:

July 7: https://aw14bfc0.aweb.page/p/b3db14be-b784-43e9-a478-927ee62aede2  

July 8: https://aw14bfc0.aweb.page/p/b50f9001-b7d0-4a7e-bc88-2a5e9757f7b9

MedX Health $MDX.ca has tons of upside, says Beacon Securities $DMTK $ICAD $PLSE $SRTS

Posted by AGORACOM-JC at 9:38 AM on Monday, July 6th, 2020
Home - MedX Health

By Jayson MacLean

Beacon Securities analyst Doug Cooper thinks the market has so far ignored a series of recent game-changing announcements by medical technology company MedX Health (MedX Health Stock Quote, Chart, News TSXV:MDX).

That scenario, said Cooper in a June 16 update to clients, makes for a prime investment opportunity.

Mississauga, Ontario-based MedX Health is developing non-invasive and cost-effective skin analysis and assessment systems for use by medical professionals. The company’s DermSecure telemedicine platform uses its SIAscopy technology which allows for images to be uploaded and sent to dermatologists for review.

MedX is now through its R&D phase with regulatory approval in 35 countries and has started commercialization.

MedX announced on Monday signing an exclusive distribution agreement to launch SIAscopy on DermSecure in Mexico through what it calls “an aggressive ease-of-access skin scanning/assessment program throughout Mexico” with partner company MedX Mexico.

MedX Mexico said it will be seeking regulatory approval, which it expects will come within the next 60 days, and then commence commercial sales.

According to the company, the opportunity in Mexico is significant, with skin cancer being a very common type of cancer in the country and with MedX’s already-established relationships there.

“MedX Mexico has experience in marketing medical devices and health solutions in the Mexican market, as well as a strong connections with hospitals, major pharmacies and medical clinics which will be a great benefit as it enters into this large market, and we are delighted to be partnering with them,” said Scott Spearn, who, as just announced on Thursday, will be stepping down immediately from the roles of president and CEO of MedX due to family reasons.

On the Mexico deal, Cooper called it, “just the latest in a series of game changing announcements from the company.”

“Yet the stock has yet to react, which we believe creates excellent opportunity for investors. Over the past few months, it has announced new distribution relationships, the imminent commencement of a pharmacy trial in Canada and the closing of a $3.3 million private placement that provided the company with necessary growth capital,” Cooper wrote.

Cooper argued that with its medical device and platform MedX is filling an unmet medical need, where on a global scale melanoma continues to be mis-diagnosed and patients have long wait times to see a dermatologist, a problem as melanoma, if untreated, can become life threatening in as little as six weeks through spread to other parts of the body.

The analyst noted MedX’s Mexican announcement comes on the heels of its exclusive distribution partnership in Brazil (also with a significant skin cancer problem, Cooper says), while on the home front, Cooper said,

“We believe MedX is about to start a trial with a high profile pharmacy chain in Canada. Given the success of the ‘proof of concept’ trial with Boots Pharmacy in Norway, we believe this will not only be successful but will also increase the company’s exposure in the investment community,” Cooper wrote.

The analyst also said he thinks MedX is continuing meaningful conversations with potential partners in the United States and Europe, while also noting there could be an expansion in market opportunity to other conditions such as rosacea, acne and eczema.

Source: https://www.cantechletter.com/2020/06/medx-health-has-tons-of-upside-says-beacon-securities/